ReviewPharmacoEconomics2015
Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective.
Nigel Fleeman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it